Novartis
Novartis officials summarized the newest activities
Published in Physician Business Week, January 16th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Novartis.
Report 1: Zelnorm (tegaserod maleate) has demonstrated potential to treat the multiple symptoms of dysmotility-type dyspepsia.
"These multiple symptoms have a very significant impact on patients' lives," said Loren Laine, MD professor of Medicine, University of Southern California School of Medicine. "For patients with moderate to severe symptoms the results of these studies are promising and suggest a benefit for tegaserod."
Pooled data from two...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week
More Articles from Physician Business Week
- Business Update
Aetna introduces new health insurance options for individuals - Business Update
Mergers and acquisitions firm MidMarket Capital advises Van Slyck on sale to Eclipsys - Business Update
Virginia Health Information publishes first hospital and nursing facility efficiency report - Addiction Medicine
Researchers from Harvard University publish new studies and findings in the area of addiction medicine - Alcoholism Therapy
Study data from University of Queensland provide new insights into alcoholism therapy - Allergies
Recent findings in allergy in children described by researchers from Children's Hospital - More from this issue of Physician Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
